EXPLORE CONNECTIONS
A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma
Follow the relationships that help you find your next source.
Connections are not prepared for this record yet, or its source metadata has changed. The original record remains available while background snapshots are rebuilt.